The Top 3 U.S. Marijuana Stocks In The Canadian Cannabis Market

As news of the Canadian government’s passing of Bill C-45, The Cannabis Act spreads momentum has already begun to pick up with marijuana stocks across the market. Pot Stock investors in the United States are looking for ways to grab a piece of the market, hoping to cash in on what many in the industry believe will be a massive run-up in stock prices. Seeing the writing on the wall, cannabis companies with ties to the United States are forming relationships with Canadian companies creating an opportunity for investors across North America to cash in on the marijuana market.  

Here are the top three Canadian marijuana stocks for U.S. investors looking to play the market:

Cannex Capital Holdings, Inc.

new TradingView.widget(
{
"width": 770,
"height": 525,
"symbol": "OTC:ARRXF",
"interval": "D",
"timezone": "Etc/UTC",
"theme": "Dark",
"style": "2",
"locale": "en",
"toolbar_bg": "#f1f3f6",
"enable_publishing": false,
"hide_top_toolbar": true,
"save_image": false,
"details": true,
"container_id": "tradingview_9e088"
}
);

Cannex Capital Holdings Inc. (CSE:CNNX), a company, focused on cannabis cultivation, extraction, and manufacturing has been acquiring U.S.-based companies in Washington and California. One of their first acquisitions was the Washington company BrightLeaf Development LLC, a company intertwined with Northwest Cannabis Solutions who deals in edibles, concentrates, and vapes. According to available information, their products are sold at the majority of cannabis retailers in Washington.   

In April, Cannex signed an agreement to acquire 100 percent of the Oakland, California based cannabis company, Jetty Extracts, opening up the California market for the Vancouver-based company.  According to Yahoo Finance, Jetty’s distribution license allows the company to deal in products without a third-party, giving them an edge up on the competition. The company has partnerships with some with of the biggest names in the cannabis industry including PAX, MedMen, and Eaze, according to reports in Yahoo Finance.

Friday Night Inc.

new TradingView.widget(
{
"width": 770,
"height": 525,
"symbol": "OTC:TGIFF",
"interval": "D",
"timezone": "Etc/UTC",
"theme": "Dark",
"style": "2",
"locale": "en",
"toolbar_bg": "#f1f3f6",
"enable_publishing": false,
"hide_top_toolbar": true,
"save_image": false,
"details": true,
"container_id": "tradingview_f236a"
}
);

Friday Night Inc. (CSE:TGIF) (FWB:1QF) is the Las Vegas-based cannabis company whose claim to fame is their 91 percent share of licensed cultivator Alternative Medicine Association. The company has shown strong sales this year, with AMA commanding a higher price on the market due to an increased focus on quality cannabis plants.

This premier marijuana stock pick has seen significant interest in Canna Hemp products in Nevada and California, making them a U.S. investors solid play on the Canadian markets. Their acquisition of Spire Secure Logistics, a cannabis security and logistics agency gives investors a diverse portfolio when investing in the company as well. Friday Night also has a hand in the CBD market with Infused MFG, owning 91 percent of that company as well, and plans to expand over 67,000 square feet back homer in Nevada.

The company is currently trading at CAD$0.57, up almost 12 percent at the time this was written.

iAnthus Capital Holdings Inc.

new TradingView.widget(
{
"width": 770,
"height": 525,
"symbol": "OTC:ITHUF",
"interval": "D",
"timezone": "Etc/UTC",
"theme": "Dark",
"style": "2",
"locale": "en",
"toolbar_bg": "#f1f3f6",
"enable_publishing": false,
"hide_top_toolbar": true,
"save_image": false,
"details": true,
"container_id": "tradingview_c8382"
}
);

Canaccord Genuity put iAnthus Capital Holdings Inc. (CNSX:IAN) on its list for top picks of 2018 earlier this year, giving the company a target price of CAD$3.90 per share. The company beat almost all expectations in January, at a time when the market was hot, hitting a near all-time high of $5.50 per share.

Today they’ve soared past that, sitting comfortably at CAD$7.50 per share, an amazing feat considering that earlier this iAnthus, like most cannabis stocks, fell victim to the market correction that hit the sector so hard. At the end of February the company announced that its 100 percent owned subsidiary Citiva Medical, LLC signed a lease for a new dispensary in Brooklyn, giving U.S. investors a solid Canadian play in one of the United State’s most populated cities. They also hold one of only ten medical marijuana "Registered Organization" licenses in the state of New York. With four dispensaries currently in the state, investors would be wise to jump on board now.

Add comment